Physician

Melissa Dove Wynn, MD

According to 2025 Medicare claims, Melissa Wynn, MD (NPI: 1215934898) practices infectious disease in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. Wynn uses personal NPI as billing NPI and primary practice location at 31419-9998.

Wynn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 589 traditional Medicare patients, billed 4,644 HCPCS/CPT codes, and received $272,571 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,119 prescription claims across 559 beneficiaries totaling $2,395,751 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2015 DME data shows 36 claims. Open Payments data shows 87 records totaling $1,590. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $983,402 to $2,395,751. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	582	5,030	$295,157
2016	635	5,275	$322,131
2017	591	5,217	$303,013
2018	671	5,330	$329,819
2019	723	5,786	$363,373
2020	679	5,198	$329,098
2021	625	5,197	$323,243
2022	666	5,387	$329,707
2023	615	5,122	$333,867
2024	589	4,644	$272,571

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	190	1,574	$983,402
2016	256	1,616	$1,301,669
2017	288	1,768	$1,352,650
2018	344	1,902	$1,197,739
2019	440	2,385	$1,946,017
2020	430	2,494	$2,113,560
2021	460	2,802	$1,807,713
2022	488	3,109	$2,741,095
2023	510	3,222	$2,810,197
2024	559	3,119	$2,395,751

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	36	$65,921
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	225	227	$118
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	118	157	$79
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	153	153	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	283	696	$57
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	318	3,290	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	172	5,160	$685,165
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	54	1,620	$210,330
Tivicay	Dolutegravir Sodium	47	1,410	$148,885
Daptomycin	Daptomycin	75	538	$145,562
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	40	1,200	$137,336

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$1,590	ViiV Healthcare Company
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Melissa Dove Wynn, MD?

Tedicare shows public-source Medicare data for Melissa Dove Wynn, MD (NPI 1215934898), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Melissa Dove Wynn, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Melissa Dove Wynn, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Melissa Dove Wynn, MD have Open Payments data?

Melissa Dove Wynn, MD has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.